Fra-1 immunoreactivity in the rat brain during normal postnatal development and after injury in adulthood

Neuroscience Research

Volumn 33, Issue 2, 1999, Pages 137-145

  Pozas, E ^a   Aguado, F ^a   Ferrer, I ^a  

^a Hospitalet   (Spain)

Author keywords

Astrocytes; Colchicine; Fra 1; GFAP; Kainic acid; Mossy fibers; Quinolinic acid

Indexed keywords

COLCHICINE; KAINIC ACID; PROTEIN C FOS; QUINOLINIC ACID; TRANSCRIPTION FACTOR FRA 1; UNCLASSIFIED DRUG;

ADULTHOOD; AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CELLULAR DISTRIBUTION; DENTATE GYRUS; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; THALAMUS; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

EID: 0032896344     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(98)00123-0     Document Type: Article

References (54)

1. Alcantara A.A., Greenough W.T. Developmental regulation of Fos and Fos-related antigens in cerebral cortex, striatum, hippocampus, and cerebellum of the rat. J. Comp. Neurol. 334:1993;75-85.
2. Ben-Ari Y. Limbic seizures and brain damage produced by kainic acid: mechanism and relevance to human temporal lobe epilepsy. Neuroscience. 14:1995;375-403.
3. Bennett M.R., Schwartz W.J. Are glia among the cells that express immunoreactive c-Fos in the suprachiasmatic nucleus? NeuroReport. 5:1994;1737-1740.
4. Bing G., Mc. Millian M., Kim H., Pennypacker K., Feng Z., Qi Q., Kong L. Y, Iadorola M, Hong J.S. Long term expression of the 35 000 mol wt Fos-related antigen in rat brain after kainic acid treatment. Neuroscience. 73:1996;1159-1174.
5. Bradford M.A. A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principal of protein DNA binding. Anal. Biochem. 72:1976;248-254.
6. Braselmam S., Berges G., Wrighton C., Graninger P., Superti-Fuga C., Busslinger B. Identification of Fos target genes by the use of selective induction systems. J. Cell Sci. Suppl. 16:1992;97-109.
7. Carillo S., Pariat M., Steff A.M., Roux P., Etienne J.M., Lorca T., Piechaczyk M. Differential sensitivity of Fos and Jun family members to calpains. Oncogene. 9:1994;1679-1689.
8. Cohen D.R., Curran T. Fra-1: a serum-inducible, cellular immediate-early gene that encodes a Fos related antigen. Mol. Cell Biol. 8:1988;2063-2069.
9. Cohen D.R., Ferreira P.C., Gentz R., Franza B.R., Curran T. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev. 3:1989;173-184.
10. Dahlstrom A. Effect of colchicine on transport of amine storage granules in sympathetic nerves of rat. Eur. J. Pharmacol. 5:1968;111-113.
11. D'Nello S.R., Heinrrich G. Structural and functional identification of regulatory regions and cis elements surrounding the nerve growth factor gene promotor. Mol. Brain Res. 11:1991;255-264.
12. Estus S., Zaks W., Freeman R.S., Gruda M., Bravo R., Johnson E.M. Altered gene expression during programmed cell death. Identification of c-Jun as necessary for neuronal apoptosis. J. Cell Biol. 127:1994;1717-1727.
13. Evers B.M., Wang X., Zhou Z., Tawsend C.M., McNeil P., Dobner D.R. Characterization of promotor elements required for cell-specific expression of the neurotensin/neuromedin N gene in a human endocrine cell line. Mol. Cell Biol. 15:1995;3870-3881.
14. Ferrer I., Martin F., Serrano T., Reiriz J., Pérez-Navarro E., Alberch J., Macaya A., Planas A.M. Both apoptosis and necrosis occur following intrastriatal administration of excitotoxins. Acta Neuropathol. 90:1995;504-510.
15. Ferrer I., Olivé M., Ribera J., Planas A.M. Naturally-occurring (programmed) and radiation-induced apoptosis are associated with selective c-Jun expression in the developing rat brain. Eur. J. Neurosci. 8:1996;1286-1298.
16. Gass P., Herdegen T. Neuronal expression of AP-1 protein expression in excitotoxic-neurodegenerative disorders and following nerve fiber lesion. Prog. Neurobiol. 47:1995;247-290.
17. Goldschmidt R.B., Steward O. Neurotoxic effect of colchicine: differential susceptibility of CNS neuronal populations. Neuroscience. 7:1982;695-714.
18. Grafstein B., . McEwen B.S., Shelanski M.L. Axonal transport of neurotubule protein. Nature. 227:1970;289-290.
19. Guerrini L., Blasi F., Denis D.S. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. USA. 92:1995;9077-9081.
20. Hadman M., Loo M., Bos T.J. In vivo viral and cellular jun complexes exhibit differential interactions with a number of in vitro generated AP-1 and CREB-like targed sequences. Oncogene. 8:1993;1895-1903.
21. Hansson H.A. Glial reactions induced by treatment with colchicine in the central nervous system of rabbits. Acta Neuropathol. 22:1972;145-157.
22. Herdegen T., Kovary K., Buhl A., Bravo R., Zimmerman M., Gass P. Basal expression of the inducible transcription factors c-Jun, Jun B, Jun D, c-Fos, Fos B, and Krox-24 in the adult rat brain. J. Comp. Neurol. 354:1995;39-56.
23. Herdegen T., Skene P., Bähr M. The c-Jun transcription factor-bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci. 20:1997;227-231.
24. Herdegen T., Zimmerman M. Expression of c-Jun and Jun D transcription factors represent specific changes in neuronal gene expression following axotomy. Prog. Brain Res. 103:1994;153-171.
25. Honkaniemi J., Kononem J., Kainu T., Pyykonen I., Pelto-Huikko M. Induction of multiple immediate early genes in rat hypothalamic paraventricular nucleus after stress. Mol. Brain Res. 25:1994;234-241.
26. Hope B.T., Keltz M.B., Duman S., Nestler E.J. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J. Neurosci. 14:1994;4318-4328.
27. Kaltschmidt C., Kaltschmidt B., Baeuerle P.A. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech. Dev. 43:1993;135-147.
28. Kaltschmidt C., Kaltschmidt B., Neumann H., Wekerle H., Baeuerle P.A. Constitutive NF-kappa B activity in neurons. Mol. Cell Biol. 14:1994;3981-3992.
29. Kamme F., Campbell K., Wichoch T. Biphasic expression of the fos and jun families of transcription factor following transient forebrain ischaemia in the rat. Effect of hypotherrmia. Eur. J. Neurosci. 7:1995;2007-2016.
30. Kato H., Kogure K., Araki T., Itoyama Y. Induction of Jun-like immunoreactivity in astrocytes in gerbil hippocampus with ischemic tolerance. Neurosci. Lett. 189:1995;13-16.
31. Kreutzberg G.W. Neuronal dynamics and axonal flow. Blockage of intra-axonal enzyme transport by colchicine. Proc. Natl. Acad. Sci. USA. 62:1969;722-728.
32. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
33. Mack K.S., Kriegler S., Chang S., Chiu S.Y. Transcription factor expression is induced by axonal stimulation and glutamate in the glia of the developing optic nerve. Mol. Brain Res. 23:1994;73-80.
34. Masood K., Besnard F., Su Y., Brenner M. Analysis of a segment of the human glial fibrillary acidic protein gene that directs astrocyte-specific transcription. J. Neurochem. 61:1993;160-166.
35. Mechta F., Lallemand D., Pfarr M., Yaniv M. Transformation by Ras modifies AP-1 composition and activity. Oncogene. 14:1997;837-847.
36. Mellstrom B., Achaval M., Montero D., Naranjo J.R., Sassone-Corsi P. Differential expression of the Jun family members in the rat brain. Oncogene. 6:1991;1959-1964.
37. Morgan J.I., Curran T. Stimulus transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Ann. Rev. Neurosci. 14:1991;421-451.
38. Ozaki T., Katsumoto E., Mui K., Furutsuka D., Yamagami S. Distribution of Fos- and Jun-related proteins and activator protein-1 composite factors in mouse brain induced by neuroleptics. Neuroscience. 84:1998;1187-1196.
39. Pechan P.A., Chowelhury K., Gerdes W., Seifert W. Glutamate induces the growth factors NGF, bFGF, the receptor FGF-R1 and c-Fos mRNA expression in rat astrocytic culture. Neurosci. Lett. 153:1993;111-114.
40. Pennypacker K.R., Hong J.S., Mullis S.B., Hudson P.M., Mc Millian M.K. Transcription factors in primary glial cultures: changes with neuronal interactions. Mol. Brain Res. 27:1996;224-230.
41. Pennypacker K.R., Thai L., Hong J.S., Mc Millian M.K. Prolonged expression of AP-1 transcription factor in the rat hippocampus after systemic kainate treatment. J. Neurosci. 14:1994;3998-4006.
42. Priller J., Haas C., Reddington M., Kreutzberg G.W. Calcitonin gene-related peptide and ATP induce immediate early gene expression in cultured rat microglial cells. Glia. 15:1995;447-457.
43. Pognone P., Boulukos K.E., Aperlo C., Fujimoto M., Arija H., Nomoto A., Kato H. Cross-family interaction between the bHLHZip USF and bZIP Fra-1 proteins results in the down regulation of AP-1 activity. Oncogene. 14:1997;2091-2098.
44. Ryseck R.P., Bravo R. c-Jun, Jun B and Jun D differ in their binding affinities to AP-1 and CRE consensus sequence: effect of Fos proteins. Oncogene. 6:1991;533-542.
45. Sarid J. Identification of a cis-acting positive regulatory element of the glial fibrillary acidic protein. J. Neurosci. Res. 28:1991;217-228.
46. Sheng M., Greenberg M.E. The regulation and function of c-Fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
47. Smeyne R.J., Vendrell M., Hayward M., Baker S.J., Miao G., Schillingk K., Robertson L.M., Curran T., Morgan J.I. Continous c-Fos expression precedes programmed cell death in vivo. Nature. 363:1993;166-169.
48. Sonnenberg J.C., Rauscher F.J., Morgan J.I., Curran T. Regulation of proencephalin by Fos and Jun. Science. 246:1989;1622-1625.
49. Sperk G. Kainic seizures in the rat. Prog. Neurobiol. 42:1991;1-32.
50. Suzuki T., Okuno H., Yoshida T., Endo T., Nishina H., Iba T. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acid Res. 19:1991;5537-5542.
51. Wilkinson D.G., Bhatt S., Ryseck R.P., Bravo R. Tissue-specific expression of c-jun and jun B during organogenesis in the mouse. Development. 106:1989;465-469.
52. Wisdon R., Verma M.I. Transformation by Fos proteins requires a C-terminal transactivation domain. Mol. Cell Biol. 13:1993;7429-7438.
53. Yoshioka K., Deng T., Cavigelli M., Karin M. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression. Proc. Natl. Acad. Sci. USA. 92:1995;4972-4976.
54. Yu A.C., Lee Y.L., Fu W.Y., Eng L.F. Gene expression in astrocytes during and after ischemia. Prog. Brain Res. 105:1995;245-253.